Yu-han Gao

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Serum interleukin-6 (Il-6) monitoring in idiopathic multicentric Castleman disease: important value in patients receiving non-anti-Il-6 therapy.

Serum interleukin-6 (Il-6) monitoring in idiopathic multicentric Castleman disease: important value in patients receiving non-anti-Il-6 therapy.

Journal: Biomarker research

Published: February 14, 2026

Ultrafast Magneto-Optical Fingerprints of Altermagnetism in MnTe.

Ultrafast Magneto-Optical Fingerprints of Altermagnetism in MnTe.

Journal: Physical review letters

Published: August 20, 2025

TAFRO Syndrome Without Pathology Supporting Castleman Disease: To Be Treated as Idiopathic Multicentric Castleman Disease-TAFRO or a Distinct Disease Entity?

TAFRO Syndrome Without Pathology Supporting Castleman Disease: To Be Treated as Idiopathic Multicentric Castleman Disease-TAFRO or a Distinct Disease Entity?

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: February 12, 2025

LRG1, a novel serum biomarker for iMCD disease activity.

LRG1, a novel serum biomarker for iMCD disease activity.

Journal: Biomarker research

Published: December 13, 2024

Rapid Relapse of Idiopathic Multicentric Castleman Disease After Siltuximab Discontinuation in a Case with Complete Remission for More Than 10 Years

Rapid Relapse of Idiopathic Multicentric Castleman Disease After Siltuximab Discontinuation in a Case with Complete Remission for More Than 10 Years

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: November 06, 2024

Research Advances in Pathogenesis of Idiopathic Multicentric Castleman Disease

Research Advances in Pathogenesis of Idiopathic Multicentric Castleman Disease

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

Published: November 06, 2024

Unicentric Castleman disease complicated with bronchiolitis obliterans: A single-centre retrospective study from China.

Unicentric Castleman disease complicated with bronchiolitis obliterans: A single-centre retrospective study from China.

Journal: British journal of haematology

Published: November 02, 2024

Clinical Characteristics and Prognosis of Pediatric Idiopathic Multicentric Castleman Disease.

Clinical Characteristics and Prognosis of Pediatric Idiopathic Multicentric Castleman Disease.

Journal: American journal of hematology

Published: October 29, 2024

Warping Effect-Induced Spin Current Absorption at Various Timescales in Fe/Bi_{2}Te_{3} Heterostructures.

Warping Effect-Induced Spin Current Absorption at Various Timescales in Fe/Bi_{2}Te_{3} Heterostructures.

Journal: Physical review letters

Published: August 16, 2024

Efficacy and safety of orelabrutinib in relapsed/refractory idiopathic multicentric Castleman disease: A single-centre, retrospective study.

Efficacy and safety of orelabrutinib in relapsed/refractory idiopathic multicentric Castleman disease: A single-centre, retrospective study.

Journal: British journal of haematology

Published: August 14, 2024

Real-world data of siltuximab for Chinese patients with iMCD: combination with BCD regimen as a potential approach for severe cases.

Real-world data of siltuximab for Chinese patients with iMCD: combination with BCD regimen as a potential approach for severe cases.

Journal: Annals of hematology

Published: June 07, 2024

Quality of life after idiopathic multicentric Castleman disease in China: a cross-sectional, multi-center survey of patient reported outcome and caregiver reported outcome.

Quality of life after idiopathic multicentric Castleman disease in China: a cross-sectional, multi-center survey of patient reported outcome and caregiver reported outcome.

Journal: Orphanet journal of rare diseases

Published: May 10, 2024

Showing 1-12 of 21

Last Updated: 09/26/2026